IAM Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
IAM Advisory's PFE Position: Q4 2024 in Review
IAM Advisory sold out of Pfizer (PFE) in Q4 2024, closing a stake of 9,264 shares — an estimated $268K sold.
IAM Advisory first reported a position in PFE in Q4 2020 and held it in 15 quarters. The position peaked at $2.28M in Q4 2022. 3,001 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- IAM Advisory reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
- IAM Advisory sold 9,264 Pfizer shares in Q4 2024, an estimated $268K.
- IAM Advisory first reported a position in Pfizer in Q4 2020 and held it in 15 quarters.
- IAM Advisory's Pfizer position peaked at $2.28M in Q4 2022.
- 3,001 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on IAM Advisory's 13F filing for Q4 2024, filed 15 Jan 2025.